Biosynex SA (FR:ALBIO) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Biosynex SA, a leading health diagnostics group, has announced its 2025 financial calendar, starting with the release of its 2024 annual revenue on January 13. The company, known for its rapid tests and molecular biology solutions, continues to expand its presence in 95 countries with a strong focus on innovation in healthcare diagnostics.
For further insights into FR:ALBIO stock, check out TipRanks’ Stock Analysis page.